These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2525057)

  • 1. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Poulin R; Baker D; Poirier D; Labrie F
    Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
    Poulin R; Baker D; Poirier D; Labrie F
    Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
    Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
    Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
    Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
    Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Couture P; Thériault C; Simard J; Labrie F
    Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
    Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
    J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice.
    Dauvois S; Geng CS; Lévesque C; Mérand Y; Labrie F
    Cancer Res; 1991 Jun; 51(12):3131-5. PubMed ID: 2039992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
    Poulin R; Baker D; Labrie F
    Breast Cancer Res Treat; 1988 Oct; 12(2):213-25. PubMed ID: 3242650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells.
    Pridjian G; Schmit V; Schreiber J
    J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor.
    Hackenberg R; Hawighorst T; Filmer A; Nia AH; Schulz KD
    Breast Cancer Res Treat; 1993; 25(3):217-24. PubMed ID: 8369523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
    Dran G; Luthy IA; Molinolo AA; Montecchia F; Charreau EH; Pasqualini CD; Lanari C
    Breast Cancer Res Treat; 1995 Aug; 35(2):173-86. PubMed ID: 7647339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition.
    Braunsberg H; Coldham NG; Leake RE; Cowan SK; Wong W
    Eur J Cancer Clin Oncol; 1987 May; 23(5):563-71. PubMed ID: 2958286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
    Labrie C; Cusan L; Plante M; Lapointe S; Labrie F
    J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
    Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens induce divergent proliferative responses in human breast cancer cell lines.
    Birrell SN; Bentel JM; Hickey TE; Ricciardelli C; Weger MA; Horsfall DJ; Tilley WD
    J Steroid Biochem Mol Biol; 1995 May; 52(5):459-67. PubMed ID: 7748811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin.
    Poulin R; Dufour JM; Labrie F
    Breast Cancer Res Treat; 1989 Jul; 13(3):265-76. PubMed ID: 2667655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of trimegestone: a new potent and selective progestin.
    Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
    Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.